Allogeneic Hematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukemia: Shifting Indications in the Era of Immunotherapy

Pediatric acute lymphoblastic leukemia generally carries a good prognosis, and most children will be cured and become long-term survivors. However, a portion of children will harbor high-risk features at the time of diagnosis, have a poor response to upfront therapy, or suffer relapse necessitating...

Descripción completa

Detalles Bibliográficos
Autores principales: Truong, Tony H., Jinca, Cristian, Mann, Georg, Arghirescu, Smaranda, Buechner, Jochen, Merli, Pietro, Whitlock, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733383/
https://www.ncbi.nlm.nih.gov/pubmed/35004545
http://dx.doi.org/10.3389/fped.2021.782785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733383/
https://www.ncbi.nlm.nih.gov/pubmed/35004545
http://dx.doi.org/10.3389/fped.2021.782785

Ejemplares similares